KRMD(KRMD)
KRMD
ANALYST COVERAGE5 analysts
BUY
▲ +81.3%upside to target
L $6.00
Med $7.00consensus
H $8.00PRICE
Prev Close
3.90
Open
3.88
Day Range3.86 – 4.01
3.86
4.01
52W Range2.63 – 6.61
2.63
6.61
31% of range
VOLUME & SIZE
Avg Volume
157.2K
FUNDAMENTALS
P/E Ratio
-77.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.69
Low vol
TECHNICAL
RSI (14)
43
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 123 days
Sep 18
Key MetricsTTM
Market Cap$179.14M
Revenue TTM$43.26M
Net Income TTM-$2.28M
Free Cash Flow$179.3K
Gross Margin61.5%
Operating Margin-6.0%
Net Margin-5.3%
Return on Equity-13.6%
Return on Assets-8.0%
Debt / Equity0.20
Current Ratio2.33
EPS TTM$-0.05
KRMD News
About
Repro Med Systems, Inc. dba KORU Medical System develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.
Adam KalbermattenPresident & Chief Commercial Officer
Christopher PazdanChief Operating Officer
Eric SchillerChief Technology Officer
Thomas AdamsChief Financial Officer, Secretary & Treasurer
Linda TharbyCEO & Director